Guides help cancer patients navigate health system, complete therapy

October 18, 2012

(Medical Xpress)—They're called patient navigators, but some might call them hurdle jumpers, task masters, or simply strong shoulders to lean on. People who first learn they might have cancer often need someone to guide them through the health system to ensure they receive tests and treatments from appropriate providers at the right time. Now, researchers have been able to confirm patient navigators play a valuable role in helping patients complete their treatment.

In a study published recently in , researchers from The Ohio State University Comprehensive Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James) found who were paired with a navigator proceeded to and treatment faster than those who were not assigned a navigator.

"There are all sorts of barriers to receiving care in a timely manner," says Electra D. Paskett, associate director for population sciences at OSUCCC-James, who led the study. "Patients may not fully understand their diagnosis or . They may not know where to go or who to contact. These are just a few examples of issues that navigators can help the patient resolve."
 
The Ohio Patient Navigator Research Program examined the Ohio model of patient navigation to determine its effectiveness at reducing the time to diagnostic resolution among patients with abnormal breast, cervical or tests or symptoms. This was one of nine such studies testing various patient navigation models in the Patient Navigator Research Program.   
 
A total of 862 patients from 18 clinics in the Columbus area participated in the research. Half (9) of the clinics were randomized to provide a patient navigator to 485 study participants, while 377 participants at the remaining clinics were provided only written educational material focusing on their specific or abnormality.
 
Patient navigators interacted with participants by phone. They identified specific barriers to care and assisted the by taking action tailored to the individual patient's needs. These actions included supportive listening, providing referrals, making appointments, facilitating communication with health care providers, helping to resolve child care or transportation problems, and providing health education. Case resolution was defined as the point at which the patient's abnormality was diagnosed as benign or cancerous.
 
After six months, the resolution rate was 36 percent higher among participants receiving navigation services than those patients not assigned a navigator. At 15 months the resolution rate was 65 percent higher than those not receiving navigation.
"This study shows that patient navigators help people get the appropriate care in a timely manner, which can go a long way toward reducing mortality from cancer," said Paskett, who is herself a breast cancer survivor.
 
Among the patients receiving navigation, 47 percent reported having no barriers to their care. Of those reporting barriers, the three most common were misperceptions about a test or treatment, communication concerns with health care providers, and difficulty scheduling appointments.
 
Unlike earlier and smaller studies of the effectiveness of patient navigation, this study examined a large and diverse group of participants in a mix of clinic types. Paskett says, in this study, the beneficial effect of patient navigation did not differ with regard to race, insurance coverage, education level or cancer type. However, there was some evidence that the benefits became evident earlier among patients with lower incomes.
 
"People from all walks of life benefit from having a navigator; someone who is a part of the clinical team and can help make sure the abnormalities are treated as soon as possible, when there is the best chance for a cure with the least medical intervention," said Paskett.
 
Patient navigators are often employed by hospitals to help patients negotiate the various complexities of the health care system. Alternatively, these services can also be provided by trained community health workers or trained volunteers.
 

Explore further: Patient navigators appear to improve colorectal cancer screening rate in ethnically diverse patients

More information: cebp.aacrjournals.org/content/21/10/1620.full

Related Stories

Patient navigators appear to improve colorectal cancer screening rate in ethnically diverse patients

May 23, 2011
Among low-income patients who are black or whose primary language is not English, patient navigators may help improve colorectal cancer (CRC) screening rates, according to a report in the May 23 issue of Archives of Internal ...

Patient navigation leads to faster diagnosis for breast cancer, according to new study

October 8, 2012
Today researchers from The George Washington University published a study showing that breast cancer patients can reduce potentially dangerous delays in the identification of breast cancer with the assistance of patient navigation ...

Patient navigators might reduce disparities in cancer care

August 17, 2011
Past research shows that minorities suffer higher rates of advanced cancer and deaths from all types of cancer compared to whites. According to an article in the August issue of Cancer, the role of “patient navigator” ...

Patient empowerment and system transformation to improve cancer care

December 14, 2011
Physicians can use medical records to track the quality of cancer care and determine whether their patients are receiving the right treatments at the right time. Yet the patient is the only one who ultimately can evaluate ...

Recommended for you

CAR-T immunotherapy may help blood cancer patients who don't respond to standard treatments

October 20, 2017
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis is one of the first centers nationwide to offer a new immunotherapy that targets certain blood cancers. Newly approved ...

Researchers pinpoint causes for spike in breast cancer genetic testing

October 20, 2017
A sharp rise in the number of women seeking BRCA genetic testing to evaluate their risk of developing breast cancer was driven by multiple factors, including celebrity endorsement, according to researchers at the University ...

Study shows how nerves drive prostate cancer

October 19, 2017
In a study in today's issue of Science, researchers at Albert Einstein College of Medicine, part of Montefiore Medicine, report that certain nerves sustain prostate cancer growth by triggering a switch that causes tumor vessels ...

Gene circuit switches on inside cancer cells, triggers immune attack

October 19, 2017
Researchers at MIT have developed a synthetic gene circuit that triggers the body's immune system to attack cancers when it detects signs of the disease.

One to 10 mutations are needed to drive cancer, scientists find

October 19, 2017
For the first time, scientists have provided unbiased estimates of the number of mutations needed for cancers to develop, in a study of more than 7,500 tumours across 29 cancer types. Researchers from the Wellcome Trust Sanger ...

Researchers target undruggable cancers

October 19, 2017
A new approach to targeting key cancer-linked proteins, thought to be 'undruggable," has been discovered through an alliance between industry and academia.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.